Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 15, 2012
Pharmaceutical Product Development, LLC (PPD) has signed a license agreement to use Tessella and Berry Consultants’ FACTSTM software to create a more flexible, intuitive approach for designing both adaptive and fixed trials.
read more
Tuesday, November 19, 2013
Clinical research associates earn top honors at PharmaTimes’ industry competition
WILMINGTON, N.C. (November 18, 2013) – Pharmaceutical Product Development, LLC (PPD) today announced that company clinical research associates (CRAs) earned ...
read more
Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Louis Renzetti, Ph.D., as vice president of strategic laboratory operations.
read more
Pharmaceutical Product Development, LLC (PPD) today introduced PPD® InVision, a data solution that consolidates and standardizes data from multiple sources, giving clients real-time access to their clinical trial data. PPD InVision’s complete, end-to...
read more
Friday, September 20, 2013
Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Gregory Dennis, M.D., as vice president of global product development. In this role, Dr. Dennis serves as therapeutic area head, providing medical and scientific expertise...
read more
Pharmaceutical Product Development, LLC (PPD) has earned the highest ratings in customer loyalty, overall value and several other attributes for Phase I services according to an Industry Standard Research (ISR) study, which evaluated 12 Phase I ...
read more
Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Jay Dixon as senior vice president, global quality and compliance. Dixon’s expertise will enhance PPD’s ability to deliver industry-leading drug development services and...
read more
Pharmaceutical Product Development, LLC (PPD) today announced the addition of Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team. De Silva will focus on key strategic initiatives vital to ...
read more
Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Henry Levy as executive vice president of client development and commercial services. Levy leads PPD’s customer-facing teams to optimize strategies and deliver results ...
read more
Pharmaceutical Product Development, LLC (PPD) today announced it has acquired Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.
read more
greenovation Biotech GmbH and Baylor Research Institute today announced positive preclinical results of greenovation’s plant-made version of human Alpha-Galactosidase (Gal) for use as enzyme-replacement-therapy (ERT) in patients suffering from Fabry ...
read more
Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302] ("Piramal"), announced that it has signed an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG ("Bayer") through its newly ...
read more
Certara, a global leader in biosimulation, announced that the FDA awarded a five-year contract with Pinnacle 21 for ongoing software and related services support for the agency’s DataFit program. The DataFit program assesses data quality and performs...
read more
Wednesday, January 19, 2022
PhoreMost Ltd., has relocated its headquarters to Unity Campus, a high-specification technology and innovation park, owned by leading regional property developers and investors, Howard Group, in south Cambridge.
read more
Wednesday, November 08, 2023
Phesi, a leading provider of patient-centered data analytics, has enhanced its Trial Accelerator™ platform by introducing the Patient Access Score (PAS). This addition empowers clinical trial sponsors to pinpoint the most effective investigators.
read more